Docs testing hashish-laced chewing gum to remedy IBS

Hashish-laced chewing gum might remedy irritable bowel syndrome, scientists consider.

Till now, docs have struggled to seek out an efficient remedy for the situation, which impacts round three.5 million People a yr.

However a group at Wageningen College within the Netherlands claims CBD – a key property in marijuana – might ease the colon spasms that appear to be the basis reason for signs.

Subsequent month, the trial will start, testing a hashish-infused chewing gum made by US agency Medical Marijuana Inc. 

Docs have struggled to seek out an efficient remedy for the situation, which impacts round three.5 million People a yr. However Dutch researchers consider a hashish-laced gum might work



The signs of irritable bowel syndrome (IBS) differ between totally different individuals.

Most victims complain of:

  • feeling bloated
  • stomach discomfort, or ache, which frequently is available in spasms
  • erratic bowel actions
  • bouts of diarrhea and constipation


There isn’t a recognized trigger for IBS. 

Many individuals with IBS discover that their signs might be affected by their weight loss plan, and their feelings, particularly stress. 

Research recommend it could possibly be brought on by spasms within the colon.  


IBS can have an effect on individuals of any age.

However it appears to be extra widespread in younger individuals.

Ladies are mostly affected, with 60 % of IBS victims feminine, in comparison with forty % male.  

The research is the primary to check a relationship between CBD (one of many two important properties in hashish) and IBS. 

Particularly, it should check a brand new product referred to as CanChew, developed my AXIM Biotechnologies, Medical Marijuana Inc’s main funding firm.

Preliminary analysis suggests the product might scale back painful abdomen cramps, management bloating, and normalize stool. 

This, they are saying, is as a result of the drug would work together with the endogenous cannabinoid receptors in victims’ digestive tract, loosening pressure. 

The trial is welcome progress for the medical marijuana business, after a big-scale report slammed most of hashish’s ‘medical advantages’ as ‘unproven’ and ‘untested’. 

It’s also a landmark for IBS analysis, because the syndrome is linked to $21 billion in medical bills, work absenteeism, and lack of productiveness.  

‘We’re excited to see that AXIM has reached one other milestone in its medical improvement program,’ stated Dr. Stuart Titus, CEO of Medical Marijuana, Inc. 

‘IBS is likely one of the commonest issues on the earth affecting as much as 15 % of the worldwide inhabitants, with no actual remedy choices out there. 

‘That is the primary development in cannabinoid analysis for remedy of IBS in medical historical past and provides a transparent instance of how far forward AXIM is in its medical improvement packages.’  

IBS is the most typical dysfunction recognized by gastroenterologists.

It accounts for as much as 12 % of complete visits to main care suppliers, accumulating between 2.four and three.5 million annual doctor visits in the USA. 

Ladies are mostly affected, with 60 % of IBS victims feminine, in comparison with forty % male.  

The gum can be given to forty trial members, aged between 18 and sixty five, alongside matching placebo gums.

All the sufferers could have been recognized with IBS based on ROME III standards – the gold normal for medical professionals.  

Within the trial, the gum will include 50mg of CBD per serving.

Sufferers might be allowed as much as six chewing gums a day to regulate their abdomen cramps, bloating, ache and different signs. 

‘The price to society when it comes to direct medical bills and oblique prices related to lack of productiveness and work absenteeism tied to IBS is appreciable,’ Dr Titus stated.

AXIM believes CanChew merchandise might additionally deal with ulcerative colitis and Crohn’s illness. 

A spokesman stated they’re able to proceed instantly with additional trials on its pharmaceutical grade if this trial is a hit. 


The most important ever report on marijuana’s results final week dismissed a lot of the drug’s different supposed ‘medical advantages’ as unproven.

Crucially, the researchers concluded there’s not sufficient analysis to say whether or not marijuana successfully treats epilepsy – probably the most extensively-acknowledged causes for hashish prescriptions.

The report additionally casts doubt on utilizing hashish to deal with cancers, irritable bowel syndrome, or sure signs of Parkinson’s illness, or serving to individuals beat addictions.

The specialists referred to as for a nationwide effort to study extra about marijuana and its chemical cousins, together with equally appearing compounds referred to as cannabinoids.

In truth, the present lack of scientific info ‘poses a public well being danger,’ stated the report, launched by the Nationwide Academies of Sciences, Engineering and Drugs.

Sufferers, well being care professionals and coverage makers want extra proof to make sound selections, it stated.

A number of elements have restricted analysis. Whereas the federal authorities has permitted some medicines containing components present in marijuana, it nonetheless classifies marijuana as unlawful and imposes restrictions on analysis. So scientists have to leap by way of bureaucratic hoops that some discover daunting, the report stated.

A federal give attention to paying for research of potential harms has additionally impeded analysis into potential well being advantages, the report stated. The vary of marijuana merchandise obtainable for research has additionally been restricted, though the federal government is increasing the variety of permitted suppliers.

Twenty-eight states and the District of Columbia have legalized marijuana for quite a lot of medical makes use of, and eight of these states plus the district have additionally legalized it for leisure use. 

Add Comment